Parkinson’s Disease – BHV8000-301

Researching an investigational treatment to change the course of Parkinson’s Disease.

If you or a loved one has been diagnosed with early-stage Parkinson’s Disease, a clinical trial might be able to help. This trial is testing a drug against brain inflammation. We are enrolling people who have Parkinson’s disease with symptoms beginning within the last two years.

Participants Must:

  • Be 40-85 years of age at the time of signing the informed consent form
  • Have a documented diagnosis of Parkinson’s disease that started within 2 years of the first (screening) study visit.
  • Not currently taking any medications for Parkinson’s disease.

Trial Interest Form